logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Lenoss Medical raised $4 million in a Series A financing to advance the OsteoPearl biological allograft implant

May 09, 2024•over 1 year ago

Amount Raised

$4 Million

Round Type

series a

ProvidenceHealth Care

Investors

Angel Investment GroupsRight Hill VenturesVodia CapitalHighpoint VenturesXcellerant Ventures

Description

Lenoss Medical, a pioneering medical device company, successfully closed an oversubscribed Series A funding round, gathering support from Xcellerant Ventures, Highpoint Ventures, Vodia Capital, RightHill Ventures, and various Angel Investment Groups. The funding will be used to accelerate commercialization, expand clinical evidence, and fuel innovative product development for the OsteoPearl implant.

Company Information

Company

Lenoss Medical

Location

Providence, Rhode Island, United States

About

Lenoss Medical engages in providing solutions that support the natural osseous healing process. They disrupt the treatment of spinal fractures with the osteopearl VBA system, a viable, minimally invasive, and cement-free technology that utilizes the natural healing properties of healthy bone.

Related People

2 contacts

Sign in to view contact details

Sign in to view contact details

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers